The company, whose headquarters migrated from St. Louis to Minneapolis about five years ago, is developing technology that aims to treat abnormally fast heart rhythms
Cardialen is a Minnesota-based medical device company that develops implantable cardioversion and defibrillation products for the treatment of atrial fibrillation.